Navigation Links
Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
Date:10/19/2009

development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2009 and the quarterly report on Form 10-Q for the quarter ended July 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release

    Contacts:
    GendeLLindheim BioCom Partners
    Investors                                             Media
    info@peregrineinc.com                                 Barbara Lindheim
    (800) 987-8256                                        (212) 918-4650

SOURCE Peregrine Pharmaceuticals, Inc.


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
2. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
3. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
4. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
5. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
6. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
7. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
8. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
9. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... , , THOUSAND OAKS, Calif., Jan. 7 Amgen ... JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time ... in San Francisco, Calif. Amgen Chairman and CEO Kevin ... presentation will be available over the Internet and can be ...
... , , TUCSON, Ariz., Jan. 7 ... Fletcher McCusker, Chairman and Chief Executive Officer, is scheduled to present ... First 2010 Micro Cap Conference on Monday, January 11, 2010 at ... is scheduled for 1:50 p.m. ET. , On Thursday, ...
Cached Medicine Technology:Amgen to Present at the 28th Annual JP Morgan Healthcare Conference 2Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities 'New Ideas for the New Year' Conference on Thursday, January 14th 2
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & Spine Center ... case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, June ... procedure was an L5-S1 posterior lumbar interbody fusion on a 69 year old, ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
(Date:7/5/2015)... ... July 06, 2015 , ... Security Life Insurance ... announce the next generation of PrimeStar Individual Dental Insurance. Beginning now, enhancements include ... network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable (UCR). , ...
(Date:7/5/2015)... ... ... Women's Excellence in Wellness, powered by Movestrong announces parent/child fitness classes this summer ... want their children to stay active as well as spend time with their child ... at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, powered by Movestrong is ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... -- A new study suggests that many mothers of overweight ... overfeeding, researchers say. "Mothers of overweight toddlers were more ... children] to accurately perceive their child,s body size," wrote a ... School of Medicine. Part of the problem, the researchers ...
... -- A new study finds that heart attack survivors who live close ... during a 10-year span. U.S. researchers looked at more than 3,500 ... those who lived less than about 330 feet from a major road ... who lived about 3,300 feet or more away. Patients who ...
... exposure to the plastic additive bisphenol A, or BPA, alters ... evidence that the chemical can be causing health problems in ... "Previous studies in mice have demonstrated that low doses ... subtle changes increase the risk of cancer in the adult," ...
... is colonised by E. coli bacteria early in life ... reveals a study of infants carried out at the Sahlgrenska Academy ... gut outnumber the cells in our bodies by a factor of ... the maturation of the immune system. The normal bacterial flora in ...
... NEW YORK, N.Y. (May 7, 2012) Autism Speaks is ... the Modified Checklist for Autism in Toddlers, or M-CHAT. The ... 16 and 30 months of age to assess their risk ... Diana Robins, Ph.D. and Deborah Fein, Ph.D. and clinical psychologist ...
... -- Scientists who found a way to make white fat ... to new obesity treatments. Brown fat burns energy (preventing ... fat cells are associated with fat accumulation around organs in ... to an increased risk for diabetes and heart disease, the ...
Cached Medicine News:Health News:In Mom's Eyes, Overweight Toddler May Not Be 2Health News:Living Near Major Roads May Shorten Heart Attack Survival 2Health News:Researchers see BPA effects in monkey mammary glands 2Health News:Gut flora affects maturation of B cells in infants 2Health News:Automated autism screening tool available on Autism Speaks website 2
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Extended modified needle - 25/box....
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
7 1/2" Bayonet Monopolar Forceps, Ins., Serrated...
Medicine Products: